Net Profit & Net Margin
SAME PT. Sarana Meditama Metropolitan Tbk
4.355.363,00
254
-6 (-2,00%)
2019
-114.384 (-21.61%)
2020
-449.464 (-88.54%)
2021
138.553 (10.9%)
2022
4.347 (0.31%)
2023
12.252 (0.8%)
RSCH PT. Charlie Hospital Semarang Tbk
572.400,00
216
-2 (-0,93%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
-1.111 (-2.64%)
DGNS PT. Diagnos Laboratorium Utama Tbk
267.500,00
214
+4 (+2,00%)
2019
n/a
2020
52.686 (28.76%)
2021
64.303 (21.28%)
2022
12.664 (6.57%)
2023
-13.655 (-9.37%)
OMED PT. Jayamas Medica Industri Tbk
5.114.113,00
189
-1 (-1,00%)
2019
n/a
2020
n/a
2021
562.692 (25.27%)
2022
285.781 (16.43%)
2023
259.359 (14.93%)
LABS PT. UBC Medical Indonesia Tbk
659.650,00
167
-7 (-4,00%)
 
SURI PT. Maja Agung Latexindo Tbk
893.146,00
141
-3 (-2,00%)
2019
n/a
2020
n/a
2021
n/a
2022
10.226 (10.96%)
2023
5.468 (6.69%)
INAF PT. Indofarma Tbk
390.508,00
126
0 (0%)
2019
7.961 (0.59%)
2020
27 (0%)
2021
-37.580 (-1.29%)
2022
-428.462 (-37.45%)
2023
n/a
PYFA PT. Pyridam Farma Tbk
1.146.143,00
102
+1 (+1,00%)
2019
9.342 (3.78%)
2020
22.104 (7.97%)
2021
5.478 (0.87%)
2022
275.241 (38.47%)
2023
-85.220 (-12.14%)
CARE PT. Metro Healthcare Indonesia Tbk
2.626.750,00
79
-1 (-1,00%)
2019
-24.205 (-15.71%)
2020
14.312 (6.62%)
2021
6.099 (2.1%)
2022
-93.543 (-39.98%)
2023
-110.919 (-45.71%)
PRIM PT. Royal Prima Tbk
199.321,00
59
-1 (-2,00%)
2019
2.396 (1.38%)
2020
38.169 (14.65%)
2021
75.433 (12.57%)
2022
21.589 (8.24%)
2023
-2.746 (-1.03%)
MMIX PT. Multi Medika Internasional Tbk
134.405,00
56
+1 (+1,79%)
2019
n/a
2020
352 (23.75%)
2021
10.331 (25.52%)
2022
23.668 (13.52%)
2023
16.512 (9.43%)
HALO PT. Haloni Jane Tbk
288.151,00
51
-1 (-2,00%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
16.996 (7.35%)
MEDS PT. Hetzer Medical Indonesia Tbk
78.125,00
50
0 (0%)
2019
n/a
2020
n/a
2021
n/a
2022
237 (0.63%)
2023
-3.570 (-15.71%)
SCPI PT. Organon Pharma Indonesia Tbk
0
0
0 (0%)
2019
112.652 (6.12%)
2020
218.362 (7.55%)
2021
118.691 (5.5%)
2022
174.782 (7.47%)
2023
187.701 (6.83%)